المؤلفون: Nina Winkelmann, Michaela Schwarz, Bert Hildebrandt, Oliver Henke, Lars Bullinger, Il‐Kang Na, Sebastian Stintzing, Philipp le Coutre

المصدر: eJHaem, Vol 3, Iss 3, Pp 949-953 (2022)

مصطلحات موضوعية: chronic myeloid leukemia, colorectal cancer, secondary malignancy, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2688-6146Test

الوصول الحر: https://doaj.org/article/54f065c65b1b4468aa13636b34af3f54Test

المؤلفون: Saglio, Giuseppe, le Coutre, Philipp, Cortes, Jorge, Mayer, Jiří, Rowlings, Philip, Mahon, François-Xavier, Kroog, Glenn, Gooden, Kyna, Subar, Milayna, Shah, Neil P

المصدر: Annals of Hematology. 96(8)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Cardiovascular, Atherosclerosis, Cancer, Hematology, Clinical Trials and Supportive Activities, Aging, Clinical Research, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cardiovascular Diseases, Clinical Trials as Topic, Dasatinib, Female, Humans, Incidence, Ischemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Middle Aged, Outcome Assessment, Health Care, Prostatic Neoplasms, Protein Kinase Inhibitors, Chronic myeloid leukemia, Ischemic, Tyrosine kinase inhibitors, Cardiorespiratory Medicine and Haematology, Immunology, Cardiovascular medicine and haematology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/1361k75xTest

المؤلفون: Diral E., Mori S., Antolini L., Abruzzese E., Le Coutre P., Martino B., Pungolino E., Elena C., Bergamaschi M., Assouline S., Di Bona E., Gozzini A., Andrade-Campos M., Stagno F., Iurlo A., Pirola A., Fontana D., Petiti J., Bonanomi M. L., Crivori P., Piazza R., Fava C., Gambacorti Passerini C.

المساهمون: Diral, E, Mori, S, Antolini, L, Abruzzese, E, Le Coutre, P, Martino, B, Pungolino, E, Elena, C, Bergamaschi, M, Assouline, S, Di Bona, E, Gozzini, A, Andrade-Campos, M, Stagno, F, Iurlo, A, Pirola, A, Fontana, D, Petiti, J, Bonanomi, M, Crivori, P, Piazza, R, Fava, C, Gambacorti Passerini, C

مصطلحات موضوعية: Imatinib, discontinuation, chronic myeloid leukemia, clinical trial, MED/15 - MALATTIE DEL SANGUE

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32518953; info:eu-repo/semantics/altIdentifier/wos/WOS:000588060700022; volume:136; issue:19; firstpage:2237; lastpage:2240; numberofpages:4; journal:BLOOD; http://hdl.handle.net/10281/315442Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85095579364

الإتاحة: https://doi.org/10.1182/BLOOD.2019004371Test
http://hdl.handle.net/10281/315442Test

المؤلفون: Gambacorti-Passerini, C, Le Coutre, P

المساهمون: Gambacorti-Passerini, C, Le Coutre, P

مصطلحات موضوعية: Chronic myeloid leukemia, BCR-ABL positive, Protein-Tyrosine Kinase, Deep molecular, MED/15 - MALATTIE DEL SANGUE

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/isbn/9781496394637; ispartofbook:DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology; firstpage:1773; lastpage:1784; numberofpages:12; http://hdl.handle.net/10281/260010Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85061184178; https://shop.lww.com/DeVita--Hellman--and-Rosenberg-s-Cancer--Principles---Practice-of-OncologyTest/p/9781496394637

الإتاحة: http://hdl.handle.net/10281/260010Test
https://shop.lww.com/DeVita--Hellman--and-Rosenberg-s-Cancer--Principles---Practice-of-OncologyTest/p/9781496394637

المؤلفون: Cortes J. E., Gambacorti-Passerini C., Deininger M. W., Mauro M. J., Chuah C., Kim D. -W., Milojkovic D., le Coutre P., Garcia-Gutierrez V., Crescenzo R., Mamolo C., Reisman A., Hochhaus A., Brummendorf T. H.

المساهمون: Cortes, J, Gambacorti-Passerini, C, Deininger, M, Mauro, M, Chuah, C, Kim, D, Milojkovic, D, le Coutre, P, Garcia-Gutierrez, V, Crescenzo, R, Mamolo, C, Reisman, A, Hochhaus, A, Brummendorf, T

مصطلحات موضوعية: Bosutinib, Chronic myeloid leukemia, Health-related quality of life, Imatinib, Patient-reported outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30989330; info:eu-repo/semantics/altIdentifier/wos/WOS:000468537100018; volume:145; issue:6; firstpage:1589; lastpage:1599; numberofpages:11; journal:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; http://hdl.handle.net/10281/259688Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85064570706; link.springer.de/link/service/journals/00432/index.htm

الإتاحة: https://doi.org/10.1007/s00432-019-02894-3Test
http://hdl.handle.net/10281/259688Test

المؤلفون: Giles, F J, Mauro, M J, Hong, F, Ortmann, C-E, McNeill, C, Woodman, R C, Hochhaus, A, le Coutre, P D, Saglio, G

مصطلحات موضوعية: chronic myeloid leukemia, nilotinib, imatinib, ponatinib, tyrosine kinase inhibitor, peripheral arterial occlusive disease, diagnosed chronic-phase, risk-factors, matrix accumulation, follow-up, prevalence, mesylate, atherosclerosis, cardiotoxicity, management, sunitinib

العلاقة: Leukemia; Giles, F J; Mauro, M J; Hong, F; Ortmann, C-E; McNeill, C; Woodman, R C; Hochhaus, A; le Coutre, P D; Saglio, G (2013). Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis. Leukemia 27 (6), 1310-1315; 0887-6924,1476-5551; http://hdl.handle.net/10379/11638Test

الإتاحة: https://doi.org/10.1038/leu.2013.69Test
http://hdl.handle.net/10379/11638Test

المؤلفون: Kim, T. D., le Coutre, P., Schwarz, M., Grille, P., Levitin, M., Fateh-Moghadam, S., Giles, F. J., Dorken, B., Haverkamp, W., Kohncke, C.

مصطلحات موضوعية: nilotinib, cardiac function, safety, heart, chronic myeloid leukemia, chronic myeloid-leukemia, long-qt syndrome, tyrosine kinase inhibitors, congestive-heart-failure, diagnosed chronic-phase, st-segment elevation, bcr-abl, philadelphia-chromosome, imatinib-resistant, cardiovascular toxicity

العلاقة: Haematologica; Kim, T. D. le Coutre, P.; Schwarz, M.; Grille, P.; Levitin, M.; Fateh-Moghadam, S.; Giles, F. J.; Dorken, B.; Haverkamp, W.; Kohncke, C. (2012). Clinical cardiac safety profile of nilotinib. Haematologica 97 (6), 883-889; 0390-6078,1592-8721; http://hdl.handle.net/10379/12274Test

الإتاحة: https://doi.org/10.3324/haematol.2011.058776Test
http://hdl.handle.net/10379/12274Test

المؤلفون: Jabbour, E, le Coutre, P D, Cortes, J, Giles, F, Bhalla, K N, Pinilla-Ibarz, J, Larson, R A, Gattermann, N, Ottmann, O G, Hochhaus, A, Hughes, T P, Saglio, G, Radich, J P, Kim, D-W, Martinelli, G, Reynolds, J, Woodman, R C, Baccarani, M, Kantarjian, H M

مصطلحات موضوعية: chronic myeloid leukemia, nilotinib, multivariate analysis, predictive model, imatinib intolerance, imatinib resistance, chronic myelogenous leukemia, tyrosine kinase inhibitors, interferon-alpha, tumor response, failure, survival, mesylate, resistance, time

العلاقة: Leukemia; Jabbour, E; le Coutre, P D; Cortes, J; Giles, F; Bhalla, K N; Pinilla-Ibarz, J; Larson, R A; Gattermann, N; Ottmann, O G; Hochhaus, A; Hughes, T P; Saglio, G; Radich, J P; Kim, D-W; Martinelli, G; Reynolds, J; Woodman, R C; Baccarani, M; Kantarjian, H M (2012). Prediction of outcomes in patients with ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance. Leukemia 27 (4), 907-913; 0887-6924,1476-5551; http://hdl.handle.net/10379/12051Test

الإتاحة: https://doi.org/10.1038/leu.2012.305Test
http://hdl.handle.net/10379/12051Test

المؤلفون: Giles, F J, Kantarjian, H M, le Coutre, P D, Baccarani, M, Mahon, F-X, Blakesley, R E, Gallagher, N J, Gillis, K, Goldberg, S L, Larson, R A, Hochhaus, A, Ottmann, O G

مصطلحات موضوعية: nilotinib, chronic myeloid leukemia, blastic phase, bcr-abl, imatinib resistance, mutations, chronic myelogenous leukemia, tyrosine kinase inhibitors, formerly amn107, dasatinib, cml, therapy, crisis, transformation, failure, cells

العلاقة: Leukemia; Giles, F J; Kantarjian, H M; le Coutre, P D; Baccarani, M; Mahon, F-X; Blakesley, R E; Gallagher, N J; Gillis, K; Goldberg, S L; Larson, R A; Hochhaus, A; Ottmann, O G (2011). Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase. Leukemia 26 (5), 959-962; 0887-6924,1476-5551; http://hdl.handle.net/10379/11636Test

الإتاحة: https://doi.org/10.1038/leu.2011.355Test
http://hdl.handle.net/10379/11636Test

المؤلفون: GAMBACORTI PASSERINI, CARLO, ANTOLINI, LAURA, PIAZZA, ROCCO GIOVANNI, POGLIANI, ENRICO MARIA, PAVESI, FILIPPO, PUTTINI, MIRIAM, MORI, SILVIA, VALSECCHI, MARIA GRAZIA, Guilhot, F, Deininger, M, Fava, C, Nagler, A, Morra, E, Abruzzese, E, D'Emilio, A, Stagno, F, le Coutre, P, Monroy, R, Santini, V, Pane, F, Giraldo, P, Assouline, S, Durosinmi, M, Leeksma, O, Rizzo, C, Dilda, I, Kim, D

المساهمون: GAMBACORTI PASSERINI, C, Antolini, L, Piazza, R, Guilhot, F, Deininger, M, Fava, C, Nagler, A, Morra, E, Abruzzese, E, D'Emilio, A, Stagno, F, le Coutre, P, Monroy, R, Santini, V, Pane, F, Giraldo, P, Assouline, S, Durosinmi, M, Leeksma, O, Pogliani, E, Pavesi, F, Puttini, M, Rizzo, C, Dilda, I, Mori, S, Kim, D, Valsecchi, M

مصطلحات موضوعية: Imatinib, Long-term effects, Chronic Myeloid Leukemia, MED/15 - MALATTIE DEL SANGUE

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000299597105494; ispartofbook:ASH 2011; 53rd Congress of the American Society of Hematology; 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis; volume:118; issue:21; firstpage:1608; lastpage:1608; numberofpages:1; journal:BLOOD; http://hdl.handle.net/10281/37646Test

الإتاحة: http://hdl.handle.net/10281/37646Test